Page 5 - Standard Biotools News Today

Investment firm Tikvah Management LLC plans to oppose SomaLogic Inc.’s (Nasdaq: SLGC) planned $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB), making Tikvah the second major investor to stake out a position against the deal in the last week or so. 

On December 26, 2023, Madryn Asset Management, LP disclosed that the Transaction Committee of SomaLogic, Inc.?s Board of Directors did not pursue a substantive dialogue with Laboratory Corporation of...

Correspondence Show SomaLogic Failed to Engage with Labcorp – One of the Industry’s Leading Strategics, with a $19 Billion Market Cap – Prior to Pursuing Standard BioTools Deal Madryn Will...

I have copied the members of our board you emailed today in the interest of providing visibility. Our merger agreement with Standard, which is publicly available, contains customary terms that...

SomaLogic Publishes Key Correspondence from LabCorp CEO Omitted by Madryn in its Attempt to Undermine Confidence in SomaLogics Thorough Strategic Process Reiterates Value-Maximizing Transaction...

/PRNewswire/ -- SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today issued the following statement in response to a press release issued...

Highlights Current Merger Consideration, Which Assigns No Value and No Premium to SomaLogic’s Desirable Assets, Represents a Material Discount to Company’s Cash Reiterates Combined Entity’s...

NEW YORK--(BUSINESS WIRE)--Dec 24, 2023--

BOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that Institutional Shareholder Services (“ISS”) has recommended that SomaLogic stockholders vote “FOR” the

NEW YORK--(BUSINESS WIRE)--Dec 22, 2023--